These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27264413)
1. Effects of 4 Statins on Regression of Coronary Plaque in Acute Coronary Syndrome. Matsushita K; Hibi K; Komura N; Akiyama E; Maejima N; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Sumita S; Umemura S; Kimura K Circ J; 2016 Jun; 80(7):1634-43. PubMed ID: 27264413 [TBL] [Abstract][Full Text] [Related]
2. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M; J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026 [TBL] [Abstract][Full Text] [Related]
3. Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study. Kuramitsu S; Miyauchi K; Yokoi H; Suwa S; Nishizaki Y; Yokoyama T; Nojiri S; Iwabuchi M; Shirai S; Ando K; Okazaki S; Tamura H; Watada H; Daida H J Cardiol; 2017 Jan; 69(1):369-376. PubMed ID: 27641967 [TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M; Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151 [TBL] [Abstract][Full Text] [Related]
5. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial. Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M; Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843 [TBL] [Abstract][Full Text] [Related]
6. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome. Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276 [TBL] [Abstract][Full Text] [Related]
14. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP; J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964 [TBL] [Abstract][Full Text] [Related]
15. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy. Matsushita K; Hibi K; Komura N; Kimura Y; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Kosuge M; Ebina T; Tamura K; Kimura K J Cardiol; 2020 Jul; 76(1):66-72. PubMed ID: 32037254 [TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
17. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study. Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100 [TBL] [Abstract][Full Text] [Related]
18. The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials. Tang X; Yang Y; Luo S; Zhao Y; Lu C; Luo Y; Zhang F; Xiao H Coron Artery Dis; 2016 Dec; 27(8):636-649. PubMed ID: 27388482 [TBL] [Abstract][Full Text] [Related]
19. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome. Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design. Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]